3EO Health
About 3EO Health
3EO Health utilizes patented 3TR amplification technology to deliver PCR-level sensitivity and specificity in respiratory diagnostics at a cost up to 70% lower than existing molecular tests. This preparation-free solution enables direct-to-test workflows, addressing the need for efficient and affordable diagnostic options in healthcare settings.
```xml <problem> Current respiratory diagnostic solutions lack a cost-effective option that combines the sensitivity and specificity of PCR-based molecular tests with the affordability and ease of use of antigen tests. Existing molecular tests are often too expensive and complex, while antigen tests suffer from suboptimal performance in detecting respiratory pathogens. </problem> <solution> 3EO Health offers a respiratory diagnostic solution leveraging its patented 3TR amplification technology to achieve PCR-level sensitivity and specificity at a significantly lower cost, up to 70% less than traditional molecular tests. The preparation-free technology enables a direct-to-test workflow, eliminating the need for time-consuming and technique-dependent sample preparation steps. This approach reduces the hidden costs associated with staff time, maintenance, quality control, and wastage. The compact design facilitates near-patient testing, making it suitable for point-of-care settings. </solution> <features> - Patented 3TR amplification technology for enhanced sensitivity and specificity - PCR-level performance with a limit of detection (LoD) of 733 copies per mL - Preparation-free, direct-to-test workflow, eliminating sample preparation steps - Compact "Cube" design for near-patient testing in various settings - Cost-effective solution with a price point comparable to antigen tests - Resilience to documented variants of respiratory pathogens </features> <target_audience> The primary target audience includes physicians, healthcare providers, and consumers seeking affordable and accurate respiratory diagnostic solutions for point-of-care testing and efficient disease management. </target_audience> ```
What does 3EO Health do?
3EO Health utilizes patented 3TR amplification technology to deliver PCR-level sensitivity and specificity in respiratory diagnostics at a cost up to 70% lower than existing molecular tests. This preparation-free solution enables direct-to-test workflows, addressing the need for efficient and affordable diagnostic options in healthcare settings.
Where is 3EO Health located?
3EO Health is based in Beverly, United States.
When was 3EO Health founded?
3EO Health was founded in 2021.
How much funding has 3EO Health raised?
3EO Health has raised 13000000.
- Location
- Beverly, United States
- Founded
- 2021
- Funding
- 13000000
- Employees
- 19 employees
- Major Investors
- MedTech Innovator